<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<ReleaseSet Dated="2016-07-04" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" Type="full" xsi:noNamespaceSchemaLocation="http://ftp.ncbi.nlm.nih.gov/pub/clinvar/xsd_public/clinvar_public_1.35.xsd">

<ClinVarSet ID="37775652"><RecordStatus>current</RecordStatus><Title>NM_000551.3(VHL):c.-75_-55del AND Von Hippel-Lindau syndrome</Title><ReferenceClinVarAssertion DateCreated="2015-01-29" DateLastUpdated="2019-01-27" ID="364387"><ClinVarAccession Acc="RCV000152657" Version="1" Type="RCV" DateUpdated="2019-01-28" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2014-12-09"><ReviewStatus>criteria provided, single submitter</ReviewStatus><Description>Likely pathogenic</Description></ClinicalSignificance><Assertion Type="variation to disease" /><AttributeSet><Attribute Type="ModeOfInheritance" integerValue="262">Autosomal dominant inheritance</Attribute><XRef ID="13905298" DB="Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine" /></AttributeSet><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>not provided</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData ID="36626489"><Attribute integerValue="6" Type="VariantAlleles" /></ObservedData><ObservedData ID="36626489"><Attribute integerValue="1" Type="NumFamiliesWithVariant" /></ObservedData></ObservedIn><MeasureSet Type="Variant" ID="166561"><Measure Type="Deletion" ID="173876"><Name><ElementValue Type="Preferred">NM_000551.3(VHL):c.-75_-55del</ElementValue></Name><AttributeSet><Attribute Change="c.-75_-55del" Accession="LRG_322t1" Type="HGVS, coding, LRG">LRG_322t1:c.-75_-55del</Attribute></AttributeSet><AttributeSet><Attribute Change="c.-75_-55del" Accession="NM_000551" Version="3" Type="HGVS, coding, RefSeq">NM_000551.3:c.-75_-55del</Attribute></AttributeSet><AttributeSet><Attribute Change="g.5139_5159del" Accession="LRG_322" Type="HGVS, genomic, LRG">LRG_322:g.5139_5159del</Attribute></AttributeSet><AttributeSet><Attribute Change="g.10141773_10141793del21" Accession="NC_000003" Version="12" Type="HGVS, genomic, top level" integerValue="38">NC_000003.12:g.10141773_10141793del21</Attribute><XRef ID="13905298" DB="ClinVar" /></AttributeSet><AttributeSet><Attribute Change="g.10183457_10183477del" Accession="NC_000003" Version="11" Type="HGVS, genomic, top level, other" integerValue="37">NC_000003.11:g.10183457_10183477del</Attribute></AttributeSet><AttributeSet><Attribute Change="g.10183457_10183477del21" Accession="NC_000003" Version="11" Type="HGVS, genomic, top level, previous" integerValue="37">NC_000003.11:g.10183457_10183477del21</Attribute></AttributeSet><AttributeSet><Attribute Change="c.-75_-55del" Accession="NM_000551" Version="2" Type="HGVS, previous">NM_000551.2:c.-75_-55del</Attribute></AttributeSet><AttributeSet><Attribute Type="Location">NM_000551.2:exon 1</Attribute></AttributeSet><CytogeneticLocation>3p25.3</CytogeneticLocation><SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="10141773" stop="10141793" display_start="10141773" display_stop="10141793" variantLength="21" positionVCF="10141769" referenceAlleleVCF="AGCGCGCACGCAGCTCCGCCCC" alternateAlleleVCF="A" /><SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="10183457" stop="10183477" display_start="10183457" display_stop="10183477" variantLength="21" referenceAllele="CGCACGCAGCTCCGCCCCGCG" alternateAllele="-" positionVCF="10183453" referenceAlleleVCF="AGCGCGCACGCAGCTCCGCCCC" alternateAlleleVCF="A" /><MeasureRelationship Type="within single gene"><Name><ElementValue Type="Preferred">von Hippel-Lindau tumor suppressor</ElementValue></Name><Symbol><ElementValue Type="Preferred">VHL</ElementValue></Symbol><AttributeSet><Attribute dateValue="2017-06-28" Type="Haploinsufficiency">Sufficient evidence for dosage pathogenicity</Attribute><Citation><URL>https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=VHL</URL></Citation></AttributeSet><AttributeSet><Attribute dateValue="2017-06-28" Type="Triplosensitivity">No evidence available</Attribute><Citation><URL>https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=VHL</URL></Citation></AttributeSet><SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="10141635" stop="10153670" display_start="10141635" display_stop="10153670" Strand="+" /><SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="10183318" stop="10195353" display_start="10183318" display_stop="10195353" variantLength="12036" Strand="+" /><XRef ID="7428" DB="Gene" /><XRef Type="MIM" ID="608537" DB="OMIM" /><XRef ID="HGNC:12687" DB="HGNC" /><Comment DataSource="NCBI curation" Type="public">This gene is cited in the ACMG recommendations of 2013 (PubMed 23788249) for reporting incidental findings in exons.</Comment><Comment DataSource="NCBI curation" Type="public">This gene is cited in the ACMG recommendations of 2016 (PubMed 27854360) for reporting incidental findings in exons.</Comment></MeasureRelationship><XRef Type="rs" ID="727503744" DB="dbSNP" /></Measure><Name><ElementValue Type="Preferred">NM_000551.3(VHL):c.-75_-55del</ElementValue></Name><XRef ID="CA020542" DB="ClinGen" /></MeasureSet><TraitSet Type="Disease" ID="570"><Trait ID="6116" Type="Disease"><Name><ElementValue Type="Preferred">Von Hippel-Lindau syndrome</ElementValue><XRef ID="Von+Hippel-Lindau+syndrome/7416" DB="Genetic Alliance" /><XRef ID="7855" DB="Office of Rare Diseases" /><XRef ID="46659004" DB="SNOMED CT" /></Name><Symbol><ElementValue Type="Preferred">VHL</ElementValue><XRef Type="MIM" ID="193300" DB="OMIM" /><XRef ID="7855" DB="Office of Rare Diseases" /></Symbol><AttributeSet><Attribute Type="public definition">Von Hippel-Lindau (VHL) syndrome is characterized by hemangioblastomas of the brain, spinal cord, and retina; renal cysts and clear cell renal cell carcinoma; pheochromocytoma, pancreatic cysts, and neuroendocrine tumors; endolymphatic sac tumors; and epididymal and broad ligament cysts. Cerebellar hemangioblastomas may be associated with headache, vomiting, gait disturbances, or ataxia. Spinal hemangioblastomas and related syrinx usually present with pain. Sensory and motor loss may develop with cord compression. Retinal hemangioblastomas may be the initial manifestation of VHL syndrome and can cause vision loss. Renal cell carcinoma occurs in about 70% of individuals with VHL and is the leading cause of mortality. Pheochromocytomas can be asymptomatic but may cause sustained or episodic hypertension. Pancreatic lesions often remain asymptomatic and rarely cause endocrine or exocrine insufficiency. Endolymphatic sac tumors can cause hearing loss of varying severity, which can be a presenting symptom. Cystadenomas of the epididymis are relatively common. They rarely cause problems, unless bilateral, in which case they may result in infertility.</Attribute><XRef ID="NBK1463" DB="GeneReviews" /></AttributeSet><AttributeSet><Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute><XRef ID="GTR000528276" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000552165" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000552183" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000552245" DB="Genetic Testing Registry (GTR)" /><XRef ID="GTR000562500" DB="Genetic Testing Registry (GTR)" /></AttributeSet><Citation Type="review" Abbrev="GeneReviews"><ID Source="PubMed">20301636</ID><ID Source="BookShelf">NBK1463</ID></Citation><Citation Type="practice guideline" Abbrev="NSGC, 2004"><ID Source="PubMed">15604628</ID></Citation><Citation Type="Recommendation" Abbrev="ACMG, 2013"><ID Source="PubMed">23788249</ID></Citation><Citation Type="practice guideline" Abbrev="ES, 2014"><ID Source="PubMed">24893135</ID></Citation><Citation Type="practice guideline" Abbrev="NANETS, 2010"><ID Source="pmc">3419007</ID></Citation><Citation Type="practice guideline" Abbrev="ACMG/NSGC, 2015"><ID Source="PubMed">25394175</ID></Citation><Citation Type="practice guideline" Abbrev="KCRNC, 2013"><ID Source="PubMed">24319509</ID></Citation><Citation Type="Recommendation" Abbrev="ACMG, 2015"><ID Source="PubMed">25356965</ID></Citation><Citation Type="Recommendation" Abbrev="ACMG, 2016"><ID Source="PubMed">27854360</ID><ID Source="DOI">10.1038/gim.2016.190</ID></Citation><XRef ID="C0019562" DB="MedGen" /><XRef ID="892" DB="Orphanet" /><XRef Type="MIM" ID="193300" DB="OMIM" /></Trait></TraitSet></ReferenceClinVarAssertion><ClinVarAssertion ID="359956" SubmissionName="SUB3719835"><ClinVarSubmissionID localKey="13905298|OMIM:193300" submittedAssembly="GRCh37" submitter="Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine" submitterDate="2018-02-23" /><ClinVarAccession Acc="SCV000202009" Version="4" Type="SCV" OrgID="21766" OrganizationCategory="laboratory" OrgType="primary" DateUpdated="2018-10-13" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2014-12-09"><ReviewStatus>criteria provided, single submitter</ReviewStatus><Description>Likely pathogenic</Description><Citation><ID Source="PubMed">22357542</ID></Citation><Citation><ID Source="PubMed">12114475</ID></Citation><Citation><ID Source="PubMed">18836774</ID></Citation><Comment Type="public">The c.-75_-55del variant in VHL has been identified by our laboratory in 1 Caucasian adult with VHL and segregated with disease in at least 5 affected relatives including 1 obligate carrier. This variant is located in the 5' untranslated region (UTR), a regulatory region, and may have an effect on translational efficiency. The deleted sequence in this variant is highly conserved in evolutionarily distant species and in vitro studies have shown that a deletion of this region removes a transcription factor binding site which is predicted to alter VHL transcription (Zatyka 2002). In summary, although additional studies are required to fully establish its clinical significance, the c.-75_-55del variant is likely pathogenic.</Comment></ClinicalSignificance><Assertion Type="variation to disease" /><ExternalID DB="Laboratory for Molecular Medicine" ID="13905298" /><AttributeSet><Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute></AttributeSet><AttributeSet><Attribute Type="AssertionMethod">LMM Criteria</Attribute><Citation><ID Source="PubMed">24033266</ID></Citation></AttributeSet><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>not provided</AffectedStatus><FamilyData NumFamiliesWithVariant="1" /></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="6" /></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><Name><ElementValue Type="Alternate">NM_000551.3:c.-75_-55del</ElementValue></Name><AttributeSet><Attribute Type="HGVS">NC_000003.11:g.10183457_10183477del</Attribute></AttributeSet><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">VHL</ElementValue></Symbol></MeasureRelationship></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><XRef DB="OMIM" ID="193300" Type="MIM" /></Trait></TraitSet></ClinVarAssertion></ClinVarSet>

</ReleaseSet>